Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene M Stratton

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Diabetes Care|November 26, 2015
Response to Comment on Leese et al. Progression of Diabetes Retinal Status Within Community Screening Programs and Potential Implications for Screening Intervals. Diabetes Care 2015;38:488-494Graham P Leese, Irene M Stratton, Martin Land, et al.
Diabetes Care|December 20, 2014
Progression of diabetes retinal status within community screening programs and potential implications for screening intervalsGraham P Leese, Irene M Stratton, Martin Land, et al.
Stroke|July 10, 2002
UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engineViti Kothari, Richard J Stevens, Amanda I Adler, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|July 30, 2014
Influence of primary care practices on patients' uptake of diabetic retinopathy screening: a qualitative case studyAntje Lindenmeyer, Jackie A Sturt, Alison Hipwell, et al.
Eye (London, England)|March 11, 2021
Epidemiology of moderately severe and severe non-proliferative diabetic retinopathy in South West EnglandClareece R Nevill, Irene M Stratton, Sonia S Maruti, et al.
Acta Ophthalmologica|June 28, 2021
Prevalence and incidence of diabetic retinopathy (DR) in the UK population of GloucestershirePeter H Scanlon, Clareece R Nevill, Irene M Stratton, et al.
Diabetologia|August 26, 2017
Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation EngineAntonio Eleuteri, Anthony C Fisher, Deborah M Broadbent, et al.
Diabetes Research and Clinical Practice|March 26, 2016
Can HbA1c detect undiagnosed diabetes in acute medical hospital admissions?Susan E Manley, Kathleen T O'Brien, Diarmuid Quinlan, et al.
Diabetologia|November 4, 2020
Safety and cost-effectiveness of individualised screening for diabetic retinopathy: the ISDR open-label, equivalence RCTDeborah M Broadbent, Amu Wang, Christopher P Cheyne, et al.
Diabetes, Obesity & Metabolism|October 5, 2018
Personalized risk-based screening for diabetic retinopathy: A multivariate approach versus the use of stratification rulesMarta García-Fiñana, David M Hughes, Christopher P Cheyne, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Diabetes Care|November 26, 2015
Response to Comment on Leese et al. Progression of Diabetes Retinal Status Within Community Screening Programs and Potential Implications for Screening Intervals. Diabetes Care 2015;38:488-494Graham P Leese, Irene M Stratton, Martin Land, et al.
Diabetes Care|December 20, 2014
Progression of diabetes retinal status within community screening programs and potential implications for screening intervalsGraham P Leese, Irene M Stratton, Martin Land, et al.
Stroke|July 10, 2002
UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engineViti Kothari, Richard J Stevens, Amanda I Adler, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|July 30, 2014
Influence of primary care practices on patients' uptake of diabetic retinopathy screening: a qualitative case studyAntje Lindenmeyer, Jackie A Sturt, Alison Hipwell, et al.
Eye (London, England)|March 11, 2021
Epidemiology of moderately severe and severe non-proliferative diabetic retinopathy in South West EnglandClareece R Nevill, Irene M Stratton, Sonia S Maruti, et al.
Acta Ophthalmologica|June 28, 2021
Prevalence and incidence of diabetic retinopathy (DR) in the UK population of GloucestershirePeter H Scanlon, Clareece R Nevill, Irene M Stratton, et al.
Diabetologia|August 26, 2017
Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation EngineAntonio Eleuteri, Anthony C Fisher, Deborah M Broadbent, et al.
Diabetes Research and Clinical Practice|March 26, 2016
Can HbA1c detect undiagnosed diabetes in acute medical hospital admissions?Susan E Manley, Kathleen T O'Brien, Diarmuid Quinlan, et al.
Diabetologia|November 4, 2020
Safety and cost-effectiveness of individualised screening for diabetic retinopathy: the ISDR open-label, equivalence RCTDeborah M Broadbent, Amu Wang, Christopher P Cheyne, et al.
Diabetes, Obesity & Metabolism|October 5, 2018
Personalized risk-based screening for diabetic retinopathy: A multivariate approach versus the use of stratification rulesMarta García-Fiñana, David M Hughes, Christopher P Cheyne, et al.
Pageof 4